Panelists at Rare Disease Day at NIH
Corrie Painter, Ph.D. (left), of Count Me In, the Massachusetts Institute of Technology and Harvard University speaks during the “Success Factors for Rare Cancer Research — Building Strong Foundations” panel session at Rare Disease Day at NIH on Feb. 28, 2019. Seated to her right are fellow panelists Jim Palma of the TargetCancer Foundation and of the Rare Cancer Coalition at the National Organization for Rare Disorders; Jack J. Welch, M.D., Ph.D., of the International Rare Cancers Initiative at the National Cancer Institute; and Denise Reinke, M.S., N.P., M.B.A., of the Sarcoma Alliance for Research Through Collaboration.
Credit: Daniel Soñé Photography
Panelists at Rare Disease Day at NIH
Corrie Painter, Ph.D. (left), of Count Me In, the Massachusetts Institute of Technology and Harvard University speaks during the “Success Factors for Rare Cancer Research — Building Strong Foundations” panel session at Rare Disease Day at NIH on Feb. 28, 2019. Seated to her right are fellow panelists Jim Palma of the TargetCancer Foundation and of the Rare Cancer Coalition at the National Organization for Rare Disorders; Jack J. Welch, M.D., Ph.D., of the International Rare Cancers Initiative at the National Cancer Institute; and Denise Reinke, M.S., N.P., M.B.A., of the Sarcoma Alliance for Research Through Collaboration.
Credit: Daniel Soñé Photography